This antibody is reactive with an extracellular loop of C5aR other than the N-terminal domain and is capable of substantially reducing or inhibiting the binding of C5a to C5aR and functional consequences of neutrophil chemoattractant receptor activation. It can also be used for treating inflammatory diseases, including autoimmune disease and graft rejection.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.